Stay updated on AstraZeneca PLC ADR Press Releases

Sign up to get notified when there's something new on the AstraZeneca PLC ADR Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the AstraZeneca PLC ADR Press Releases page

  1. Check
    yesterday
    Change Detected
    Summary
    The latest press releases now feature an EU approval for Enhertu and new clinical findings for several AstraZeneca medicines, alongside other recent regulatory and trial updates. Earlier October releases about hypophosphatasia, a Cambridge R&D centre and Summit Therapeutics have dropped off the listing.
    Difference
    5%
    Check dated 2026-10-27T23:21:52.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The latest releases now feature Tezspire trial results, an AstraZeneca–Oracle AI collaboration, upcoming ESMO survival data, and a new insitro collaboration. Older announcements about bladder cancer review, myasthenia gravis data, youth health equity, and Trixeo approval have been replaced.
    Difference
    5%
    Check dated 2026-10-20T22:45:33.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The latest press release feed now features October 2026 updates on hypophosphatasia trial results, upcoming conference data, a new R&D centre, and investments and collaborations, while several earlier September releases have dropped off the list.
    Difference
    5%
    Check dated 2026-10-13T22:37:20.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    New press release headlines with dates have been added to the page, highlighting recent corporate activity, regulatory progress, and product news. Older press release entries have been removed from the listing.
    Difference
    5%
    Check dated 2026-09-29T22:56:52.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    Three new press releases were added highlighting EU CHMP recommendations and US Priority Review for multiple therapies (including Klygefa for generalised myasthenia gravis, Enhertu in the EU, and Efzimfotase alfa in the US, dated 18 September 2026). Four older items were removed from the archive: the Zegfrovy lung cancer license, Tagrisso plus Orpathys PFS results, Tezspire eosinophilic esophagitis results, and an entry dated 27 August 2026.
    Difference
    5%
    Check dated 2026-09-22T23:10:43.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    New entries were added to the press releases list, including DESTINY-Lung04 and ADAURA Phase III updates with dates, as well as SERENA-4 updates. Some older trial-result entries were removed from the list.
    Difference
    5%
    Check dated 2026-09-15T21:48:03.000Z thumbnail image

Stay in the know with updates to AstraZeneca PLC ADR Press Releases

Enter your email address, and we'll notify you when there's something new on the AstraZeneca PLC ADR Press Releases page.